Study to Determine the Safety and Effectiveness of Dupilumab for Treatment of Atopic Dermatitis (AD)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Quantitative MRI for Myelofibrosis
- Status
- RECRUITING
- Phase
- N/A
Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia
- Status
- COMPLETED
- Phase
- PHASE2
Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Open Label Study of Long Term Safety Evaluation of Alirocumab
- Status
- COMPLETED
- Phase
- PHASE3
A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Open-label Study of Dupilumab in Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)
- Status
- COMPLETED
- Phase
- PHASE3
An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of Sinusitis
- Status
- COMPLETED
- Phase
- PHASE2
Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Ph II Cabazitaxel DD Liposarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2